Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;17(5):253-255.
doi: 10.1038/s41575-020-0294-8.

Management of IBD during the COVID-19 outbreak: resetting clinical priorities

Silvio Danese  1   2 , Maurizio Cecconi  3   4 , Antonino Spinelli  3   5
Affiliations

Management of IBD during the COVID-19 outbreak: resetting clinical priorities

Silvio Danese et al. Nat Rev Gastroenterol Hepatol. 2020 May.

Erratum in

Abstract

The coronavirus disease (COVID-19) worldwide outbreak has led to a dramatic challenge for all healthcare systems, including inflammatory bowel disease (IBD) centres. Here, we describe the fast changes and clinical issues that IBD specialists could face during this SARS-CoV-2 infection pandemic, highlighting the potential rearrangements of care and resetting of clinical priorities.

PubMed Disclaimer

Conflict of interest statement

S.D. has served as a speaker, a consultant and an advisory board member for Abbvie, Ferring, Hospira, Johnson & Johnson, Merck, Millennium Takeda, Mundipharma, Pfizer, Tigenix, UCB Pharma and Vifor. A.S. has served as a Consultant or speaker for Ethicon, Frankenman, Oasis, Pfizer, Takeda and Sofar. M.C. has served as a consultant or speaker for Cheetah Medical, Directed Systems and Edwards Lifesciences.

Figures

Fig. 1
Fig. 1. Approaches to minimize spread of infectious disease for patients with IBD during COVID-19.
a | The WHO recommends basic protective measures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for the general public, including washing hands frequently and maintaining social distancing. b | The International Organization for the study of Inflammatory Bowel Disease (IOIBD) have made several recommendations for patients with inflammatory bowel disease (IBD) related to coronavirus disease (COVID-19), including the continuation of immunosuppressants. c | Strategies to enable maintenance of our biologic agent clinic during the COVID-19 outbreak in Italy include checkpoints at hospital entrances for symptom screening and use of surgical masks for clinical staff and patients. aBasic protective measures for the public according to the WHO. bRecommendations by IOIBD correct as of 16 Mar 2020. cExperience at the IBD Center, Humanitas University, Milan, Italy.
See this image and copyright information in PMC

References

    1. Wang D, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069. doi: 10.1001/jama.2020.1585. - DOI - PMC - PubMed
    1. Huang C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed
    1. Johns Hopkins University & Medicine. Coronavirus COVID-19 global cases. Coronavirus resource centerhttps://coronavirus.jhu.edu/map.html (2020).
    1. Ling, Y. et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin. Med. J. (Engl.)10.1097/CM9.0000000000000774 (2020). - PMC - PubMed
    1. Xu Y, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020 doi: 10.1038/s41591-020-0817-4. - DOI - PMC - PubMed

MeSH terms

Substances